Lyndsey Sandow, Justin Grenet, Adel Kardosh, Emerson Yu-sheng Chen, Guillaume Joe Pegna, Skye C. Mayo, Robert Eil, Patrick Joseph Worth, Flavio G. Rocha, Nima Nabavizadeh, Aaron Grossberg, Alexander Guimaraes, Bryan Foster, Shaun M. Goodyear, Erin Taber, Dove Keith, Gordon Brent Mills, Rosalie C. Sears, Brett C. Sheppard, Charles D. Lopez. "NeoOPTIMIZE: Phase II trial of adaptive switching of neoadjuvant FOLFIRINOX (FFX) to gemcitabine/nab-paclitaxel (GA) resectable/borderline resectable (BR)/locally advanced (LA) pancreatic adenocarcinoma (PDAC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4190